Notably, comprehensive gene expression and breast cancer tissue microarray analyses reveal that USP30 is significantly downregulated in TNBC and CSCs, with reduced nuclear localization in tumors, suggesting clinical relevance. The gene discussed is USP30; the disease is breast carcinoma.